Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development
The Pharma Data
NOVEMBER 19, 2020
. Structure-based design approach has identified potent compounds for further development as oral treatments for SARS-CoV-2 infection and related human coronaviruses. TOKYO and CAMBRIDGE, England , Nov. TOKYO and CAMBRIDGE, England , Nov. The program was initiated in April 2020.
Let's personalize your content